Cargando…

Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?

The current Covid-19 pandemic has pointed out some major deficiencies of the even most advanced societies to fight against viral RNA infections. Once more, it has been demonstrated that there is a lack of efficient drugs to control RNA viruses. Aptamers are efficient ligands of a great variety of mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berzal-Herranz, Alfredo, Romero-López, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463695/ https://www.ncbi.nlm.nih.gov/pubmed/32707768 http://dx.doi.org/10.3390/ph13080157

Ejemplares similares

Aptamers: Biomedical Interest and Applications
por: Romero-López, Cristina, et al.
Publicado: (2017)

RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region
por: Fernández-Sanlés, Alba, et al.
Publicado: (2015)

Potential of the Other Genetic Information Coded by the Viral RNA Genomes as Antiviral Target
por: Berzal-Herranz, Alfredo, et al.
Publicado: (2019)

Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element
por: Marton, Soledad, et al.
Publicado: (2011)

Application of Aptamers in Virus Detection and Antiviral Therapy
por: Zou, Xinran, et al.
Publicado: (2019)

5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
por: Hwang, Sun-Young, et al.
Publicado: (2012)

Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses
por: González, Víctor M., et al.
Publicado: (2016)

Binding Interactions of Peptide Aptamers
por: New, Roger R. C., et al.
Publicado: (2020)

Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies
por: Sánchez-Luque, Francisco J., et al.
Publicado: (2014)

The Role of the RNA-RNA Interactome in the Hepatitis C Virus Life Cycle
por: Romero-López, Cristina, et al.
Publicado: (2020)

The Influence of Protein Charge and Molecular Weight on the Affinity of Aptamers
por: Drees, Alissa, et al.
Publicado: (2023)

Characterization of DNA aptamers generated against the soft-shelled turtle iridovirus with antiviral effects
por: Li, Pengfei, et al.
Publicado: (2015)

Selection and Characterization of ssDNA Aptamers Targeting Largemouth Bass Virus Infected Cells With Antiviral Activities
por: Yu, Qing, et al.
Publicado: (2021)

RNA–protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamers
por: Lange, Margaret J., et al.
Publicado: (2017)

Application of aptamers for assessment of vaccine efficacy
por: Yoon, Soo Young, et al.
Publicado: (2017)

Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
por: Yoshitomi, Toru, et al.
Publicado: (2021)

The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome
por: Romero-López, Cristina, et al.
Publicado: (2017)

Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
por: Faquih, Tariq, et al.
Publicado: (2021)

RNA Aptamer Evolution: Two Decades of SELEction
por: Aquino-Jarquin, Guillermo, et al.
Publicado: (2011)

Inter- and Intramolecular RNA–RNA Interactions Modulate the Regulation of Translation Mediated by the 3′ UTR in West Nile Virus
por: Romero-López, Cristina, et al.
Publicado: (2023)

Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010)

Aptamers as Both Drugs and Drug-Carriers
por: Ashrafuzzaman, Md.
Publicado: (2014)

Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome
por: Romero-López, Cristina, et al.
Publicado: (2017)

In silico selection of RNA aptamers
por: Chushak, Yaroslav, et al.
Publicado: (2009)

RAPID-SELEX for RNA Aptamers
por: Szeto, Kylan, et al.
Publicado: (2013)

Identification of Aptamer-Binding Sites in Hepatitis C Virus Envelope Glycoprotein E2
por: Chen, Fan, et al.
Publicado: (2015)

Generation of Nucleic Acid Aptamer Candidates against a Novel Calicivirus Protein Target
por: Faircloth, Jeremy, et al.
Publicado: (2021)

Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
por: Gelinas, Amy D., et al.
Publicado: (2023)

In Vitro Methods to Decipher the Structure of Viral RNA Genomes
por: Romero-López, Cristina, et al.
Publicado: (2021)

Evaluation of Antiviral Activity of Zanthoxylum Species Against Picornaviruses
por: Choi, Hwa-Jung
Publicado: (2016)

Pharmacological Agents with Antiviral Activity against Monkeypox Infection
por: Zovi, Andrea, et al.
Publicado: (2022)

The HCV genome domains 5BSL3.1 and 5BSL3.3 act as managers of translation
por: Romero-López, Cristina, et al.
Publicado: (2018)

Fabrication and characterization of RNA aptamer microarrays for the study of protein–aptamer interactions with SPR imaging
por: Li, Yuan, et al.
Publicado: (2006)

Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
por: Nakajima, Shogo, et al.
Publicado: (2023)

The Genomic 3′ UTR of Flaviviruses Is a Translation Initiation Enhancer
por: Berzal-Herranz, Alfredo, et al.
Publicado: (2022)

An RNA-aptamer-based two-color CRISPR labeling system
por: Wang, Siyuan, et al.
Publicado: (2016)

In Vitro Antiviral Activity of Sakuranetin against Human Rhinovirus 3
por: Choi, Hwa-Jung
Publicado: (2017)

Aptamer Bioinformatics
por: Kinghorn, Andrew B., et al.
Publicado: (2017)

Aptamer Sensors
por: Marrazza, Giovanna
Publicado: (2017)

Aptamers as therapeutics
por: Keefe, Anthony D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_09rdtmhqig1gpe8m80q17b0qou